Navigation Links
Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
Date:5/31/2008

Robust Pathway Inhibition in Tumor and Surrogate Tissues at Well-Tolerated

Doses

CHICAGO, May 31 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) reported interim data from a phase 1 dose-escalation trial of XL765, a novel small molecule inhibitor of phosphoinositide-3 kinase (PI3K) and mTOR, which are implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy. The trial is being carried out in patients with metastatic or unresectable solid tumors for which known effective measures do not exist or are no longer effective. Kyriakos Papadopoulos, MD, Clinical Investigator at South Texas Accelerated Research Therapeutics (START) and a lead investigator in the trial, presented the data in the PI-3 Kinase/mTOR Directed Agents oral abstract session (Abstract #3510) at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).

There were 19 patients available for safety, pharmacokinetic, and tumor response analyses as of the May 1, 2008 cutoff. Results from pharmacodynamics analyses indicate that XL765 inhibits the PI3K/mTOR pathway in patients at well-tolerated doses. Reductions of 80-90% in the phosphorylation of pathway components including AKT, 4EBP1, and S6, and a reduction of 54% in cell proliferation (as assessed by Ki67 staining) were observed in tumor tissue from a patient with chondrosarcoma at the 60 mg twice-a-day (BID) dose level. Reductions in the phosphorylation of these pathway components were also observed at this dose level in surrogate patient tissues, including hair bulbs, skin, and peripheral blood cells. The pattern of inhibition of protein phosphorylation observed in these tissues is consistent with observations
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GlaxoSmithKline Accelerates Review of Exelixis XL880
2. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference
6. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
7. Phase 2 Trial Results for Exelixis XL784 Presented at the 2007 American Society of Nephrology Conference
8. Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
9. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
10. Exelixis Announces First Quarter 2008 Financial Results
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ... Internet.  Simply log onto our website listed above.   ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/29/2015)... June 30, 2015 , Gerresheimer will ... Corning and Gerresheimer enter into a 10-year-supply agreement for ... EUR 196m debt-free Corning and Gerresheimer ... pharmaceutical glass packaging market Gerresheimer,s outlook for the ... future disposal of the tubing business , In ...
(Date:6/29/2015)... 2015  Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... Officer of Intersect ENT (NASDAQ: XENT ), has ... 28, 2015. For the last seven ... ENT, a company dedicated to improving the quality of ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... WASHINGTON, Oct. 19, 2011 Sharon Ladin, director ... Project, issued the following statement regarding the bipartisan, ... today by Sen. Richard Blumenthal (D-Conn.) and Sen. ... to H.R. 2182 and contains provisions to incentivize ...
... The maker of MidNite ® Sleep ... formula, has succeeded in protecting the brand against patent ... president, Holly Rosenthal. Under the terms of the agreement ... Sleep Remedy, and Contract Pharmacal (CPC), a contract manufacturer ...
Cached Medicine Technology:Popular Sleep Supplement Brand Settles Patent Infringement Suit Against Store Brand Manufacturer 2
(Date:6/30/2015)... Long Beach, CA (PRWEB) , ... June 30, 2015 , ... ... Sea Skilled Nursing”, which features multiple patient and family member testimonials. Medicare rated the ... the country. Broadway plans to use the video to give future patients a firsthand ...
(Date:6/30/2015)... ... June 30, 2015 , ... The progress of ... multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, ... to the Court’s calendar, that conference has now been scheduled for July 9th, ...
(Date:6/30/2015)... ... 2015 , ... Allied Anesthesia physicians are committed to giving ... help provide free outpatient procedures to some of Orange County’s neediest residents during ... , The event was coordinated by AccessOC, which was founded in 2007 ...
(Date:6/30/2015)... NC (PRWEB) , ... June 30, 2015 , ... ... Virginia” title in a recent online poll at http://scoutology.com/novaburgerwars and was selected ... to be published in August 2015. , Red Hot & Blue President Randy McCann ...
(Date:6/30/2015)... ... , ... New Energy Works Timberframers invites the public to join their timber ... and beam raisings offer a chance to witness the culmination of months of planning, ... important and exciting event – it is an age-old craft where the bones of ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4
... available in German . , Cancer ... the course of time, genetic mutations often accumulate in ... tumour growth. Using a mathematical model, scientists at the ... University of Pennsylvania and University of California San Francisco, ...
... 19, 2011 The University of Maryland School of ... opportunities to advance the science of medicine and improve ... the Department by the National Institutes of Health (NIH). ... qualitative excellence of the University of Maryland programs. ...
... , SUNDAY, Dec. 18 (HealthDay News) -- ... because people are cooking more, putting up potentially flammable ... a significant increase in burn patients between Thanksgiving and ... and celebration, can quickly turn tragic," Dr. Jeff Guy, ...
... Dec. 19 (HealthDay News) -- Obese Americans have smaller paychecks ... strong among women, a new study finds. The analysis ... that in 2004, overall average annual incomes were $8,666 less ... with normal weight workers. In 2008, obese women made ...
... trials have highlighted the beneficial effect of cardiac ... and reduction of mortality, and CRT is now ... for the treatment and prevention of heart failure.(1), ... subjects and their results are not always applicable ...
... that increases brain levels of an important regulatory enzyme ... Huntington,s disease (HD) and other neurodegenerative disorders. In ... Medicine , a Massachusetts General Hospital (MGH)-based research team ... family of enzymes called sirtuins, in the brain of ...
Cached Medicine News:Health News:Tissue structure delays cancer development 2Health News:Tissue structure delays cancer development 3Health News:University of Maryland Department of surgery continues to lead through surgical innovation 2Health News:University of Maryland Department of surgery continues to lead through surgical innovation 3Health News:Christmas Trees and Trappings Can Fan Fire Risk 2Health News:Obesity Linked to Lower Paychecks 2Health News:The benefits of cardiac resynchronisation therapy in heart failure 2Health News:The benefits of cardiac resynchronisation therapy in heart failure 3Health News:Regulatory enzyme overexpression may protect against neurodegeneration in Huntington's disease 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Medicine Products: